+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
CRISPR & Cas Genes Market by Application (Agricultural Biotechnology, Animal Model Development, Diagnostics), End User (Biotechnology Companies, Contract Research Organizations, Pharmaceutical Companies), Cas Type, Delivery Method, Technology - Global Forecast 2025-2030- Product Image
CRISPR & Cas Genes Market by Application (Agricultural Biotechnology, Animal Model Development, Diagnostics), End User (Biotechnology Companies, Contract Research Organizations, Pharmaceutical Companies), Cas Type, Delivery Method, Technology - Global Forecast 2025-2030- Product Image
Sale

CRISPR & Cas Genes Market by Application (Agricultural Biotechnology, Animal Model Development, Diagnostics), End User (Biotechnology Companies, Contract Research Organizations, Pharmaceutical Companies), Cas Type, Delivery Method, Technology - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 180 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6011578
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The CRISPR & Cas Genes Market is experiencing significant momentum as organizations increasingly leverage genome editing for targeted research and therapeutic applications. This sector is drawing heightened attention from executives aiming to drive innovation, streamline R&D, and secure competitive advantages amid evolving biotechnological landscapes.

Market Snapshot: CRISPR & Cas Genes Market Growth and Outlook

The CRISPR & Cas Genes Market grew from USD 5.04 billion in 2024 to USD 6.74 billion in 2025. It is expected to continue growing at a CAGR of 32.49%, reaching USD 27.30 billion by 2030.

Scope & Segmentation of the CRISPR & Cas Genes Market

This report provides in-depth analysis and revenue forecasts across several segments, empowering leadership teams to identify growth opportunities by application, user profile, technology, and region:

  • Application: Agricultural biotechnology, animal model development, diagnostics, gene editing for research and therapeutic use, and gene therapy.
  • End User: Biotechnology companies (including both established firms and startups), contract research organizations (offering clinical and preclinical services), pharmaceutical companies (including biopharma and large pharma), and research institutes.
  • Cas Type: Cas9, Cas12, Cas13, Cas14.
  • Delivery Method: Electroporation, liposome transfection, microinjection, nanoparticle delivery (lipid and polymer nanoparticles), and viral vectors (adeno associated virus, adenovirus, lentivirus).
  • Technology: Ex vivo (cell line engineering, primary cell modification) and in vivo approaches (clinical trials, preclinical models).
  • Region: Americas (U.S. states including California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio), Canada, Mexico, Brazil, Argentina, EMEA (including the UK, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), and Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Key Companies: Thermo Fisher Scientific, Danaher Corporation, Merck KGaA, QIAGEN, Agilent Technologies, Illumina, PerkinElmer, GenScript Biotech, Bio-Rad Laboratories, Synthego Corporation.

Key Takeaways for Decision-Makers

  • The market is driven by the precision and versatility of CRISPR & Cas technology, enabling efficient genetic modifications across diverse organisms for both research and clinical settings.
  • Expansion into advanced gene therapy, diagnostics, and agricultural segments is broadening commercial opportunities for established enterprises and disruptive startups alike.
  • Newer enzyme variants and engineered delivery platforms are addressing off-target effects, enhancing safety profiles, and expanding use cases to gene regulation and epigenetic modulation.
  • Strategic collaborations among academic institutes, biotechs, and instrumentation providers are strengthening supply chains and fostering integrated solutions that streamline product development.
  • Regional differentiation in adoption curves is influenced by regulatory environments, funding landscapes, and access to skilled talent pools, requiring tailored go-to-market approaches.

Tariff Impact: Navigating Recent U.S. Trade Levies

Recently imposed U.S. tariffs on imported CRISPR reagents and Cas proteins are prompting cost increases and supply chain adjustments. Organizations are mitigating these impacts by partnering with domestic suppliers, optimizing purchasing strategies, and fostering industry collaborations to build supply resilience and local capacity.

Methodology & Data Sources

This report leverages robust primary research, including detailed interviews with domain experts and strategic decision-makers, as well as secondary research from scholarly literature, patent filings, regulatory disclosures, clinical trial registries, and conference proceedings. Data validation uses proprietary datasets and scenario modeling to ensure reliability and actionable insights.

Why This Report Matters

  • Enables informed strategic decision-making in genome editing by detailing opportunities and challenges across the value chain.
  • Guides investment and partnership strategies aligned with diverse regulatory, technological, and regional factors.
  • Supports operational resilience by highlighting trends influencing supply, manufacturing, and competitive dynamics.

Conclusion

Leaders navigating genome editing markets can leverage this report to anticipate industry shifts, capitalize on growth segments, and strengthen organizational positioning. The findings equip stakeholders to make confident decisions in an evolving CRISPR & Cas innovation landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Advancements in base editing technologies driving precision gene therapies with reduced off-target effects
5.2. Commercial adoption of CRISPR prime editing platforms for treatment of genetic disorders in clinical pipelines
5.3. Emergence of in vivo delivery vehicles optimizing CRISPR Cas protein complexes for targeted tissue specificity
5.4. Strategic partnerships between biotech firms and contract research organizations to accelerate CRISPR screening services
5.5. Regulatory frameworks evolving to address ethical considerations around human germline gene editing trials
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. CRISPR & Cas Genes Market, by Application
8.1. Introduction
8.2. Agricultural Biotechnology
8.3. Animal Model Development
8.4. Diagnostics
8.4.1. Disease Detection
8.4.2. Genetic Screening
8.5. Gene Editing
8.5.1. Research Applications
8.5.2. Therapeutic Applications
8.6. Gene Therapy
9. CRISPR & Cas Genes Market, by End User
9.1. Introduction
9.2. Biotechnology Companies
9.2.1. Established Firms
9.2.2. Startups
9.3. Contract Research Organizations
9.3.1. Clinical Services
9.3.2. Preclinical Services
9.4. Pharmaceutical Companies
9.4.1. Biopharma Firms
9.4.2. Large Pharma
9.5. Research Institutes
10. CRISPR & Cas Genes Market, by Cas Type
10.1. Introduction
10.2. Cas12
10.3. Cas13
10.4. Cas14
10.5. Cas9
11. CRISPR & Cas Genes Market, by Delivery Method
11.1. Introduction
11.2. Electroporation
11.3. Liposome Transfection
11.4. Microinjection
11.5. Nanoparticle Delivery
11.5.1. Lipid Nanoparticles
11.5.2. Polymer Nanoparticles
11.6. Viral Vector
11.6.1. Adeno Associated Virus
11.6.2. Adenovirus
11.6.3. Lentivirus
12. CRISPR & Cas Genes Market, by Technology
12.1. Introduction
12.2. Ex Vivo
12.2.1. Cell Line Engineering
12.2.2. Primary Cell Modification
12.3. In Vivo
12.3.1. Clinical Trials
12.3.2. Preclinical Models
13. Americas CRISPR & Cas Genes Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa CRISPR & Cas Genes Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific CRISPR & Cas Genes Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Thermo Fisher Scientific Inc.
16.3.2. Danaher Corporation
16.3.3. Merck KGaA
16.3.4. QIAGEN N.V.
16.3.5. Agilent Technologies, Inc.
16.3.6. Illumina, Inc.
16.3.7. PerkinElmer, Inc.
16.3.8. GenScript Biotech Corporation
16.3.9. Bio-Rad Laboratories, Inc.
16.3.10. Synthego Corporation
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. CRISPR & CAS GENES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY CAS TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY CAS TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY DELIVERY METHOD, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY DELIVERY METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC CRISPR & CAS GENES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC CRISPR & CAS GENES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. CRISPR & CAS GENES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. CRISPR & CAS GENES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. CRISPR & CAS GENES MARKET: RESEARCHAI
FIGURE 26. CRISPR & CAS GENES MARKET: RESEARCHSTATISTICS
FIGURE 27. CRISPR & CAS GENES MARKET: RESEARCHCONTACTS
FIGURE 28. CRISPR & CAS GENES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CRISPR & CAS GENES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CRISPR & CAS GENES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CRISPR & CAS GENES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY AGRICULTURAL BIOTECHNOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY ANIMAL MODEL DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY ANIMAL MODEL DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY DISEASE DETECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY DISEASE DETECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY GENETIC SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY GENETIC SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY GENE EDITING, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY GENE EDITING, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY RESEARCH APPLICATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY RESEARCH APPLICATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY THERAPEUTIC APPLICATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY GENE EDITING, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY GENE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY ESTABLISHED FIRMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY ESTABLISHED FIRMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY STARTUPS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY STARTUPS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY CLINICAL SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY CLINICAL SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY PRECLINICAL SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY PRECLINICAL SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY BIOPHARMA FIRMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY BIOPHARMA FIRMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY LARGE PHARMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY LARGE PHARMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY CAS TYPE, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY CAS TYPE, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY CAS12, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY CAS12, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY CAS13, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY CAS13, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY CAS14, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY CAS14, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY CAS9, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY CAS9, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY ELECTROPORATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY ELECTROPORATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY LIPOSOME TRANSFECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY LIPOSOME TRANSFECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY MICROINJECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY MICROINJECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY NANOPARTICLE DELIVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY NANOPARTICLE DELIVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY LIPID NANOPARTICLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY LIPID NANOPARTICLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY POLYMER NANOPARTICLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY POLYMER NANOPARTICLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY NANOPARTICLE DELIVERY, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY NANOPARTICLE DELIVERY, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY VIRAL VECTOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY VIRAL VECTOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY ADENO ASSOCIATED VIRUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY ADENO ASSOCIATED VIRUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY ADENOVIRUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY ADENOVIRUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY LENTIVIRUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY LENTIVIRUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY VIRAL VECTOR, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY VIRAL VECTOR, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY EX VIVO, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY EX VIVO, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY CELL LINE ENGINEERING, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY CELL LINE ENGINEERING, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY PRIMARY CELL MODIFICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY PRIMARY CELL MODIFICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY EX VIVO, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY EX VIVO, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY IN VIVO, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY IN VIVO, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY PRECLINICAL MODELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY PRECLINICAL MODELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY IN VIVO, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY IN VIVO, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY GENE EDITING, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY CAS TYPE, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY CAS TYPE, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY NANOPARTICLE DELIVERY, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY NANOPARTICLE DELIVERY, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY VIRAL VECTOR, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY VIRAL VECTOR, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY EX VIVO, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY EX VIVO, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY IN VIVO, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY IN VIVO, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY GENE EDITING, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY CAS TYPE, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY CAS TYPE, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY NANOPARTICLE DELIVERY, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY NANOPARTICLE DELIVERY, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY VIRAL VECTOR, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY VIRAL VECTOR, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY EX VIVO, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY EX VIVO, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY IN VIVO, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY IN VIVO, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 175. CANADA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 176. CANADA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 177. CANADA CRISPR & CAS GENES MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 178. CANADA CRISPR & CAS GENES MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 179. CANADA CRISPR & CAS GENES MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
TABLE 180. CANADA CRISPR & CAS GENES MARKET SIZE, BY GENE EDITING, 2025-2030 (USD MILLION)
TABLE 181. CANADA CRISPR & CAS GENES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. CANADA CRISPR & CAS GENES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. CANADA CRISPR & CAS GENES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 184. CANADA CRISPR & CAS GENES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 185. CANADA CRISPR & CAS GENES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 186. CANADA CRISPR & CAS GENES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 187. CANADA CRISPR & CAS GENES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 188. CANADA CRISPR & CAS GENES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 189. CANADA CRISPR & CAS GENES MARKET SIZE, BY CAS TYPE, 2018-2024 (USD MILLION)
TABLE 190. CANADA CRISPR & CAS GENES MARKET SIZE, BY CAS TYPE, 2025-2030 (USD MILLION)
TABLE 191. CANADA CRISPR & CAS GENES MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 192. CANADA CRISPR & CAS GENES MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 193. CANADA CRISPR & CAS GENES MARKET SIZE, BY NANOPARTICLE DELIVERY, 2018-2024 (USD MILLION)
TABLE 194. CANADA CRISPR & CAS GENES MARKET SIZE, BY NANOPARTICLE DELIVERY, 2025-2030 (USD MILLION)
TABLE 195. CANADA CRISPR & CAS GENES MARKET SIZE, BY VIRAL VECTOR, 2018-2024 (USD MILLION)
TABLE 196. CANADA CRISPR & CAS GENES MARKET SIZE, BY VIRAL VECTOR, 2025-2030 (USD MILLION)
TABLE 197. CANADA CRISPR & CAS GENES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 198. CANADA CRISPR & CAS GENES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 199. CANADA CRISPR & CAS GENES MARKET SIZE, BY EX VIVO, 2018-2024 (USD MILLION)
TABLE 200. CANADA CRISPR & CAS GENES MARKET SIZE, BY EX VIVO, 2025-2030 (USD MILLION)
TABLE 201. CANADA CRISPR & CAS GENES MARKET SIZE, BY IN VIVO, 2018-2024 (USD MILLION)
TABLE 202. CANADA CRISPR & CAS GENES MARKET SIZE, BY IN VIVO, 2025-2030 (USD MILLION)
TABLE 203. MEXICO CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 204. MEXICO CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 205. MEXICO CRISPR & CAS GENES MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 206. MEXICO CRISPR & CAS GENES MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 207. MEXICO CRISPR & CAS GENES MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
TABLE 208. MEXICO CRISPR & CAS GENES MARKET SIZE, BY GENE EDITING, 2025-2030 (USD MILLION)
TABLE 209. MEXICO CRISPR & CAS GENES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. MEXICO CRISPR & CAS GENES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. MEXICO CRISPR & CAS GENES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 212. MEXICO CRISPR & CAS GENES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 213. MEXICO CRISPR & CAS GENES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 214. MEXICO CRISPR & CAS GENES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 215. MEXICO CRISPR & CAS GENES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 216. MEXICO CRISPR & CAS GENES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 217. MEXICO CRISPR & CAS GENES MARKET SIZE, BY CAS TYPE, 2018-2024 (USD MILLION)
TABLE 218. MEXICO CRISPR & CAS GENES MARKET SIZE, BY CAS TYPE, 2025-2030 (USD MILLION)
TABLE 219. MEXICO CRISPR & CAS GENES MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 220. MEXICO CRISPR & CAS GENES MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 221. MEXICO CRISPR & CAS GENES MARKET SIZE, BY NANOPARTICLE DELIVERY, 2018-2024 (USD MILLION)
TABLE 222. MEXICO CRISPR & CAS GENES MARKET SIZE, BY NANOPARTICLE DELIVERY, 2025-2030 (USD MILLION)
TABLE 223. MEXICO CRISPR & CAS GENES MARKET SIZE, BY VIRAL VECTOR, 2018-2024 (USD MILLION)
TABLE 224. MEXICO CRISPR & CAS GENES MARKET SIZE, BY VIRAL VECTOR, 2025-2030 (USD MILLION)
TABLE 225. MEXICO CRISPR & CAS GENES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 226. MEXICO CRISPR & CAS GENES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 227. MEXICO CRISPR & CAS GENES MARKET SIZE, BY EX VIVO, 2018-2024 (USD MILLION)
TABLE 228. MEXICO CRISPR & CAS GENES MARKET SIZE, BY EX VIVO, 2025-2030 (USD MILLION)
TABLE 229. MEXICO CRISPR & CAS GENES MARKET SIZE, BY IN VIVO, 2018-2024 (USD MILLION)
TABLE 230. MEXICO CRISPR & CAS GENES MARKET SIZE, BY IN VIVO, 2025-2030 (USD MILLION)
TABLE 231. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 232. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 233. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 234. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 235. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
TABLE 236. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY GENE EDITING, 2025-2030 (USD MILLION)
TABLE 237. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 240. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 241. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 242. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 243. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 244. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 245. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY CAS TYPE, 2018-2024 (USD MILLION)
TABLE 246. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY CAS TYPE, 2025-2030 (USD MILLION)
TABLE 247. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 248. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 249. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY NANOPARTICLE DELIVERY, 2018-2024 (USD MILLION)
TABLE 250. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY NANOPARTICLE DELIVERY, 2025-2030 (USD MILLION)
TABLE 251. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY VIRAL VECTOR, 2018-2024 (USD MILLION)
TABLE 252. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY VIRAL VECTOR, 2025-2030 (USD MILLION)
TABLE 253. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 254. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 255. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY EX VIVO, 2018-2024 (USD MILLION)
TABLE 256. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY EX VIVO, 2025-2030 (USD MILLION)
TABLE 257. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY IN VIVO, 2018-2024 (USD MILLION)
TABLE 258. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY IN VIVO, 2025-2030 (USD MILLION)
TABLE 259. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 260. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 261. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 262. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 263. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
TABLE 264. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY GENE EDITING, 2025-2030 (USD MILLION)
TABLE 265. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 268. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 269. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 270. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 271. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 272. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 273. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY CAS TYPE, 2018-2024 (USD MILLION)
TABLE 274. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY CAS TYPE, 2025-2030 (USD MILLION)
TABLE 275. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 276. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 277. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY NANOPARTICLE DELIVERY, 2018-2024 (USD MILLION)
TABLE 278. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY NANOPARTICLE DELIVERY, 2025-2030 (USD MILLION)
TABLE 279. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY VIRAL VECTOR, 2018-2024 (USD MILLION)
TABLE 280. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY VIRAL VECTOR, 2025-2030 (USD MILLION)
TABLE 281. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 282. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 283. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY EX VIVO, 2018-2024 (USD MILLION)
TABLE 284. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY EX VIVO, 2025-2030 (USD MILLION)
TABLE 285. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY IN VIVO, 2018-2024 (USD MILLION)
TABLE 286. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY IN VIVO, 2025-2030 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 289. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 290. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 291. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY GENE EDITING, 2025-2030 (USD MILLION)
TABLE 293. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 296. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 297. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 298. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 299. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 300. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 301. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY CAS TYPE, 2018-2024 (USD MILLION)
TABLE 302. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY CAS TYPE, 2025-2030 (USD MILLION)
TABLE 303. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 304. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 305. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY NANOPARTICLE DELIVERY, 2018-2024 (USD MILLION)
TABLE 306. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY NANOPARTICLE DELIVERY, 2025-2030 (USD MILLION)
TABLE 307. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY VIRAL VECTOR, 2018-2024 (USD MILLION)
TABLE 308. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY VIRAL VECTOR, 2025-2030 (USD MILLION)
TABLE 309. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 310. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 311. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY EX VIVO, 2018-2024 (USD MILLION)
TABLE 312. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY EX VIVO, 2025-2030 (USD MILLION)
TABLE 313. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY IN VIVO, 2018-2024 (USD MILLION)
TABLE 314. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY IN VIVO, 2025-2030 (USD MILLION)
TABLE 315. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 316. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 317. UNITED KINGDOM CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 318. UNITED KINGDOM CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 319. UNITED KINGDOM CRISPR & CAS GENES MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 320. UNITED KINGDOM CRISPR & CAS GENES MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 321. UNITED KINGDOM CRISPR & CAS GENES MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
TABLE 322. UNITED KINGDOM CRISPR & CAS GENES MARKET SIZE, BY GENE EDITING, 2025-2030 (USD MILLION)
TABLE 323. UNITED KINGDOM CRISPR & CAS GENES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 324. UNITED KINGDOM CRISPR & CAS GENES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 325. UNITED KINGDOM CRISPR & CAS GENES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 326. UNITED KINGDOM CRISPR & CAS GENES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 327. UNITED KINGDOM CRISPR & CAS GENES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 328. UNITED KINGDOM CRISPR & CAS GENES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 329. UNITED KINGDOM CRISPR & CAS GENES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 330. UNITED KINGDOM CRISPR & CAS GENES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 331. UNITED KINGDOM CRISPR & CAS GENES MARKET SIZE, BY CAS TYPE, 2018-2024 (USD MILLION)
TABLE 332. UNITE

Samples

Loading
LOADING...

Companies Mentioned

  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Merck KGaA
  • QIAGEN N.V.
  • Agilent Technologies, Inc.
  • Illumina, Inc.
  • PerkinElmer, Inc.
  • GenScript Biotech Corporation
  • Bio-Rad Laboratories, Inc.
  • Synthego Corporation

Table Information

Report AttributeDetails
No. of Pages180
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 6.74 Billion
Forecasted Market Value ( USD ) by 2030 $ 27.3 Billion
Compound Annual Growth Rate32.4%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

CRISPR Gene Editing Market by Type, Application, End User, Delivery Method - Global Forecast to 2030 - Product Image

CRISPR Gene Editing Market by Type, Application, End User, Delivery Method - Global Forecast to 2030

  • Report
  • 197 Pages
  • Global
From
Gene Editing Market by CRISPR, Technology, Application, End User - Global Forecast to 2030 - Product Image

Gene Editing Market by CRISPR, Technology, Application, End User - Global Forecast to 2030

  • Report
  • 195 Pages
  • Global
From
CRISPR And Cas Genes Market Size, Share & Trends Analysis Report By Product & Service (Kits & Reagents, Cell Line Engineering), By Application (Biomedical, Agricultural), By End Use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

CRISPR And Cas Genes Market Size, Share & Trends Analysis Report By Product & Service (Kits & Reagents, Cell Line Engineering), By Application (Biomedical, Agricultural), By End Use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
CRISPR-based Gene Editing Market Size, Share and Trends Analysis Report by Product & Service (CRISPR Kits & Reagents), Application (Biomedical, Agricultural), End-use, and Region 2024-2030 - Product Image

CRISPR-based Gene Editing Market Size, Share and Trends Analysis Report by Product & Service (CRISPR Kits & Reagents), Application (Biomedical, Agricultural), End-use, and Region 2024-2030

  • Report
  • 120 Pages
  • Global
From
Global CRISPR Cas9 Market Opportunity & Clinical Trials Outlook 2029 - Product Image

Global CRISPR Cas9 Market Opportunity & Clinical Trials Outlook 2029

  • Report
  • 180 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.